Cerebain Biotech Corp. to Hold Conference Call
Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of
Discount Dental Materials, Inc. (OTCBB: DDOO) announced today it intends
to hold a conference call on July 1st at 3:30 p.m. EST. The
purpose of the call is to permit Dr. Surinder Saini, Chairman of the
Company’s Scientific Advisory Board, an opportunity to provide the
genesis of and thought processes surrounding the Company’s efforts to
develop the world's first medical device specifically designed for the
treatment of Alzheimer’s disease utilizing the Omentum. Investors and
Analysts may join the conference call by dialing 712-432-9998, and
entering access code 126307#.
About Discount Dental Materials, Inc.
Discount Dental Materials, Inc. was incorporated in Nevada on December
17, 2007. The Company’s business involves the discovery of products for
the treatment of Alzheimer’s disease utilizing Omentum. The Company’s
planned products include both a medical device solution as well as a
synthetic drug solution. The Company’s operations are conducted through
its wholly-owned subsidiary, Cerebain Biotech Corp. For more information
about Discount Dental and Cerebain Biotech, please visit the Company’s
website at www.cerebain.com
under the ticker symbol “DDOO”, to view the Company’s public filings and
Forward Looking Statements
This news release contains certain "forward-looking statements."
Forward-looking statements are based on current expectations and
assumptions and are inherently subject to risks and uncertainties, some
of which cannot be predicted or quantified, and many of which are beyond
the Company's control. The forward-looking statements are also
identified through the use of words "believe,” "enable," "may," "will,"
"could," "intends," "estimate," "anticipate," "plan," "predict"
"probable," "potential," "possible," "should," "continue," and other
words of similar meaning. Actual results could differ materially from
these forward-looking statements as a result of a number of risk factors
detailed in the Company's reports filed with OTC Markets. Given these
risks and uncertainties, investors are cautioned not to place undue
reliance on such forward-looking statements and no assurances can be
given that such statements will be achieved.
Copyright Business Wire 2013